![Standing with Dr. Timnit Gebru — #ISupportTimnit #BelieveBlackWomen | by Google Walkout For Real Change | Medium Standing with Dr. Timnit Gebru — #ISupportTimnit #BelieveBlackWomen | by Google Walkout For Real Change | Medium](https://miro.medium.com/v2/resize:fit:960/1*by49TbavMf9UjTcKTxVbFQ.jpeg)
Standing with Dr. Timnit Gebru — #ISupportTimnit #BelieveBlackWomen | by Google Walkout For Real Change | Medium
![A dual endosymbiosis supports nutritional adaptation to hematophagy in the invasive tick Hyalomma marginatum | eLife A dual endosymbiosis supports nutritional adaptation to hematophagy in the invasive tick Hyalomma marginatum | eLife](https://iiif.elifesciences.org/lax/72747%2Felife-72747-fig3-v1.tif/full/1500,/0/default.jpg)
A dual endosymbiosis supports nutritional adaptation to hematophagy in the invasive tick Hyalomma marginatum | eLife
![PDF) The future of research on tick-borne pathogens: shifting from the 'one pathogen-one disease' vision to the pathobiome paradigm PDF) The future of research on tick-borne pathogens: shifting from the 'one pathogen-one disease' vision to the pathobiome paradigm](https://i1.rgstatic.net/publication/341987122_The_future_of_research_on_tick-borne_pathogens_shifting_from_the_'one_pathogen-one_disease'_vision_to_the_pathobiome_paradigm/links/5f75aa41458515b7cf5c75a1/largepreview.png)
PDF) The future of research on tick-borne pathogens: shifting from the 'one pathogen-one disease' vision to the pathobiome paradigm
![Cyclodextrin-Based Polymeric Materials: Synthesis, Properties, and Pharmaceutical/Biomedical Applications | Biomacromolecules Cyclodextrin-Based Polymeric Materials: Synthesis, Properties, and Pharmaceutical/Biomedical Applications | Biomacromolecules](https://pubs.acs.org/cms/10.1021/bm901065f/asset/images/medium/bm-2009-01065f_0013.gif)
Cyclodextrin-Based Polymeric Materials: Synthesis, Properties, and Pharmaceutical/Biomedical Applications | Biomacromolecules
![Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.8b01492/asset/images/medium/jm-2018-01492k_0002.gif)
Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry
![Patrick AIMEDIEU | Research Engineer | French National Centre for Scientific Research, Paris | CNRS | Laboratoire Navier | Research profile Patrick AIMEDIEU | Research Engineer | French National Centre for Scientific Research, Paris | CNRS | Laboratoire Navier | Research profile](https://i1.rgstatic.net/ii/profile.image/1065677217607680-1631088656583_Q512/Patrick-Aimedieu.jpg)